M.J.A. van Wijland

649 total citations
17 papers, 533 citations indexed

About

M.J.A. van Wijland is a scholar working on Molecular Biology, Surgery and Clinical Biochemistry. According to data from OpenAlex, M.J.A. van Wijland has authored 17 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Clinical Biochemistry. Recurrent topics in M.J.A. van Wijland's work include Peroxisome Proliferator-Activated Receptors (10 papers), Metabolism and Genetic Disorders (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). M.J.A. van Wijland is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (10 papers), Metabolism and Genetic Disorders (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). M.J.A. van Wijland collaborates with scholars based in Netherlands, United States and France. M.J.A. van Wijland's co-authors include H. van den Bosch, J. M. Tager, Carlo W.T. van Roermund, A. W. Schram, Albert K. Groen, R. B. H. Schutgens, R. J. A. Wanders, R. B. H. Schutgens, Ronald J. A. Wanders and Ronald P.J. Oude Elferink and has published in prestigious journals such as Gastroenterology, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

M.J.A. van Wijland

17 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J.A. van Wijland Netherlands 12 366 196 161 131 121 17 533
H Mochizuki United States 7 305 0.8× 165 0.8× 94 0.6× 90 0.7× 53 0.4× 15 565
T. Shirotani Japan 8 316 0.9× 90 0.5× 183 1.1× 162 1.2× 28 0.2× 11 623
Patricia Passilly France 8 463 1.3× 59 0.3× 62 0.4× 200 1.5× 84 0.7× 13 587
Isabelle Suc France 7 238 0.7× 52 0.3× 185 1.1× 51 0.4× 42 0.3× 7 554
Christiane Legendre France 6 305 0.8× 43 0.2× 111 0.7× 167 1.3× 42 0.3× 6 487
Anne-Charlotte Lilljeqvist Norway 7 217 0.6× 127 0.6× 146 0.9× 55 0.4× 25 0.2× 9 382
Ayako Ojima Japan 15 241 0.7× 271 1.4× 138 0.9× 80 0.6× 54 0.4× 18 771
Seikoh Horiuchi Japan 8 132 0.4× 172 0.9× 133 0.8× 58 0.4× 17 0.1× 9 439
John A. Dlugosz Canada 12 218 0.6× 89 0.5× 95 0.6× 77 0.6× 33 0.3× 12 494
Hongying Gan‐Schreier Germany 14 194 0.5× 112 0.6× 83 0.5× 36 0.3× 47 0.4× 28 485

Countries citing papers authored by M.J.A. van Wijland

Since Specialization
Citations

This map shows the geographic impact of M.J.A. van Wijland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J.A. van Wijland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J.A. van Wijland more than expected).

Fields of papers citing papers by M.J.A. van Wijland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J.A. van Wijland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J.A. van Wijland. The network helps show where M.J.A. van Wijland may publish in the future.

Co-authorship network of co-authors of M.J.A. van Wijland

This figure shows the co-authorship network connecting the top 25 collaborators of M.J.A. van Wijland. A scholar is included among the top collaborators of M.J.A. van Wijland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J.A. van Wijland. M.J.A. van Wijland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Hovingh, G. Kees, M.J.A. van Wijland, Alison Brownlie, et al.. (2003). The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. Journal of Lipid Research. 44(6). 1251–1255. 40 indexed citations
3.
Wijland, M.J.A. van, Dirk R. de Waart, & Albert K. Groen. (2001). Biliary Anionic Peptide Fraction/Calcium Binding Protein Inhibits Apolipoprotein A-I-Mediated Cholesterol Efflux from Cultured Cells. Biochemical and Biophysical Research Communications. 287(1). 1–4. 7 indexed citations
4.
Frijters, C.M.G., et al.. (1997). Regulation of mdr2 P-glycoprotein expression by bile salts. Biochemical Journal. 321(2). 389–395. 42 indexed citations
5.
Frijters, C.M.G., et al.. (1996). Influence of bile salts on hepatic mdr2 P-glycoprotein expression. Advances in Enzyme Regulation. 36. 351–363. 18 indexed citations
6.
Wijland, M.J.A. van, et al.. (1995). Regulation of protein secretion into bile: Studies in mice with a disrupted mdr2 p-glycoprotein gene. Gastroenterology. 109(6). 1997–2006. 29 indexed citations
7.
Porte, P. Lechène de la, et al.. (1995). Localization of biliary proteins, Ca, Cu, P, S, in the pigment and cholesterol zones of mixed gallstones. Gastroenterology. 108(4). A1107–A1107. 1 indexed citations
8.
Wijland, M.J.A. van, et al.. (1994). Heterogeneity of Human Biliary Mucin: Functional Implications. Clinical Science. 86(1). 75–82. 9 indexed citations
9.
Wijland, M.J.A. van, et al.. (1994). Heterogeneity of Human Gallbladder Mucin in Bile. Clinical Science. 86(1). 67–74. 14 indexed citations
10.
Wanders, R. J. A., Carlo W.T. van Roermund, M.J.A. van Wijland, et al.. (1988). Peroxisomes and peroxisomal functions in hyperpipecolic acidaemia. Journal of Inherited Metabolic Disease. 11(S2). 161–164. 11 indexed citations
11.
Wanders, R. J. A., Carlo W.T. van Roermund, M.J.A. van Wijland, et al.. (1988). Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. Biochemical and Biophysical Research Communications. 153(2). 618–624. 131 indexed citations
12.
Wanders, Ronald J. A., Carlo W.T. van Roermund, M.J.A. van Wijland, et al.. (1988). X‐linked adrenoleukodystrophy: Identification of the primary defect at the level of a deficient peroxisomal very long chain fatty acyl‐CoA synthetase using a newly developed method for the isolation of peroxisomes from skin fibroblasts. Journal of Inherited Metabolic Disease. 11(S2). 173–177. 26 indexed citations
13.
Wanders, R. J. A., M.J.A. van Wijland, R. B. H. Schutgens, et al.. (1987). X-Linked adrenoleukodystrophy: Defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters. Clinica Chimica Acta. 165(2-3). 321–329. 48 indexed citations
14.
Wanders, Ronald J. A., Carlo W.T. van Roermund, M.J.A. van Wijland, et al.. (1987). Peroxisomal very long-chain fatty acid β-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders. Clinica Chimica Acta. 166(2-3). 255–263. 43 indexed citations
15.
Wanders, Ronald J. A., Carlo W.T. van Roermund, M.J.A. van Wijland, et al.. (1987). Peroxisomal fatty acid β‐oxidation in human skin fibroblasts: X‐linked adrenoleukodystrophy, a peroxisomal very long chain fatty acyl‐CoA synthetase deficiency?. Journal of Inherited Metabolic Disease. 10(S2). 220–224. 8 indexed citations
16.
Wanders, Ronald J. A., Carlo W.T. van Roermund, M.J.A. van Wijland, et al.. (1987). Studies on the peroxisomal oxidation of palmitate and lignocerate in rat liver. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 919(1). 21–25. 38 indexed citations
17.
Wanders, Ronald J. A., M.J.A. van Wijland, Carlo W.T. van Roermund, et al.. (1987). Prenatal diagnosis of Zellweger syndrome by measurement of very long chain fatty acid (C26 : 0) β-oxidation in cultured chorionic villous fibroblasts: Implications for early diagnosis of other peroxisomal disorders. Clinica Chimica Acta. 165(2-3). 303–310. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026